Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting

Alcohol and Alcoholism

Volumn 47, Issue 5, 2012, Pages 552-557

  Helander, Anders ^a   Péter, Oszkár ^b   Zheng, Yufang ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; ETHYL GLUCURONIDE; ETHYL SULFATE; PHOSPHATIDYLETHANOLAMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIMIT OF QUANTITATION; MALE; MASS SPECTROMETRY; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RELAPSE; URINALYSIS;

ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; AMBULATORY CARE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; FEMALE; GLUCURONATES; GLYCEROPHOSPHOLIPIDS; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; SULFURIC ACID ESTERS; TRANSFERRIN;

EID: 84865340269     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/ags065     Document Type: Article

References (36)

1. Aradottir S, Asanovska G, Gjerss S et al. (2006) Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 41:431-7.
2. Aradottir S, Olsson BL. (2005) Methodological modifications on quantification of phosphatidylethanol in blood from humans abusing alcohol, using high-performance liquid chromatography and evaporative light scattering detection. BMC Biochem 6:18.
3. Arndt T, van der Meijden BB, Wielders JP. (2008) Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping. Clin Chim Acta 394:42-6.
4. Beck O, Helander A. (2003) 5-Hydroxytryptophol as a marker for recent alcohol intake. Addiction 98(Suppl 2):63-72.
5. Bergström JP, Helander A. (2008a) Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers. Alcohol Alcohol 43:436-41.
6. Bergström JP, Helander A. (2008b) Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta 388:59-67.
7. Conigrave KM, Degenhardt LJ, Whitfield JB et al. (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26:332-9.
8. Dahl H, Stephanson N, Beck O et al. (2002) Comparison of urinary excretion characteristics of ethanol and ethyl glucuronide. J Anal Toxicol 26:201-4.
9. Erim Y, Böttcher M, Dahmen U et al. (2007) Urinary ethyl glucuronide testing detects alcohol consumption in alcoholic liver disease patients awaiting liver transplantation. Liver Transpl 13:757-61.
10. Gustavsson L. (1995) Phosphatidylethanol formation: specific effects of ethanol mediated via phospholipase D. Alcohol Alcohol 30:391-406.
11. Helander A, Beck O. (2004) Mass spectrometric identification of ethyl sulfate as an ethanol metabolite in humans. Clin Chem 50:936-7.
12. Helander A, Beck O. (2005) Ethyl sulfate: a metabolite of ethanol in humans and a potential biomarker of acute alcohol intake. J Anal Toxicol 29:270-4.
13. Helander A, Beck O, Jones AW. (1996) Laboratory testing for recent alcohol consumption: comparison of ethanol, methanol, and 5-hydroxytryptophol. Clin Chem 42:618-24.
14. Helander A, Böttcher M, Fehr C et al. (2009) Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcohol 44:55-61.
15. Helander A, Husa A, Jeppsson J-O. (2003) Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem 49:1881-90.
16. Helander A, Kenan N, Beck O. (2010) Comparison of analytical approaches for liquid chromatography/mass spectrometry determination of the alcohol biomarker ethyl glucuronide in urine. Rapid Commun Mass Spectrom 24:1737-43.
17. Helander A, von Wachenfeldt J, Hiltunen A et al. (1999) Comparison of urinary 5-hydroxytryptophol, breath ethanol, and self-report for detection of recent alcohol use during outpatient treatment: a study on methadone patients. Drug Alcohol Depend 56:33-8.
18. Helander A, Zheng Y. (2009) Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. Clin Chem 55:1395-405.
19. Hermansson U, Helander A, Brandt L et al. (2011) Screening and brief intervention for risky alcohol consumption in the workplace: results of a 1-year randomized controlled study. Alcohol Alcohol 45:252-7.
20. Hoiseth G, Bernard JP, Stephanson N et al. (2008) Comparison between the urinary alcohol markers EtG, EtS, and GTOL/5-HIAA in a controlled drinking experiment. Alcohol Alcohol 43:187-91.
21. Isaksson A, Walther L, Hansson T et al. (2011) Phosphatidylethanol in blood (B-PEth): a marker for alcohol use and abuse. Drug Test Anal 3:195-200.
22. Jeppsson J-O, Arndt T, Schellenberg F et al. (2007) Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med 45:558-62.
23. Kenan N, Larsson A, Axelsson O et al. (2011) Changes in transferrin glycosylation during pregnancy may lead to falsepositive carbohydrate-deficient transferrin (CDT) results in testing for riskful alcohol consumption. Clin Chim Acta 412:129-33.
24. Maisto SA, Saitz R. (2003) Alcohol use disorders: screening and diagnosis. Am J Addict 12(Suppl 1):S12-25.
25. Nalesso A, Viel G, Cecchetto G et al. (2011) Quantitative profiling of phosphatidylethanol molecular species in human blood by liquid chromatography high resolution mass spectrometry. J Chromatogr A 1218:8423-31.
26. Neumann T, Helander A, Dahl H et al. (2008) Value of ethyl glucuronide in plasma as a biomarker for recent alcohol consumption in the emergency room. Alcohol Alcohol 43:431-5.
27. Niemelä O, Alatalo P. (2010) Biomarkers of alcohol consumption and related liver disease. Scand J Clin Lab Invest 70:305-12.
28. Palmer RB. (2009) A review of the use of ethyl glucuronide as a marker for ethanol consumption in forensic and clinical medicine. Semin Diagn Pathol 26:18-27.
29. Schmitt G, Aderjan R, Keller T et al. (1995) Ethyl glucuronide: an unusual ethanol metabolite in humans. Synthesis, analytical data, and determination in serum and urine. J Anal Toxicol 19:91-4.
30. Stephanson N, Dahl H, Helander A et al. (2002) Direct quantification of ethyl glucuronide in clinical urine samples by liquid chromatography-mass spectrometry. Ther Drug Monit 24:645-51.
31. Stewart SH, Law TL, Randall PK et al. (2010) Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol Clin Exp Res 34:488-92.
32. Stewart SH, Reuben A, Brzezinski WA et al. (2009) Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol 44:464-7.
33. Stibler H. (1991) Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 37:2029-37.
34. Varga A, Hansson P, Johnson G et al. (2000) Normalization rate and cellular localization of phosphatidylethanol in whole blood from chronic alcoholics. Clin Chim Acta 299:141-50.
35. Wurst FM, Thon N, Aradottir S et al. (2010) Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict Biol 15:88-95.
36. Zheng Y, Beck O, Helander A. (2011) Method development for routine liquid chromatography-mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood. Clin Chim Acta 412:1428-35.